Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Miguel A. Hernán, Elena Ferrer et al.|The Lancet HIV|2015Cited by 68
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income CountriesEllen C. Caniglia, Miguel A. Hernán, Caroline Sabin et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 27
Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individualsMiguel A. Hernán, James M. Robins, Lauren E. Cain et al.|Statistics in Medicine|2019Cited by 25
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational studyEllen C. Caniglia, Miguel A. Hernán, Lauren E. Cain et al.|The Lancet HIV|2017Cited by 15
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomesLauren E. Cain, Miguel A. Hernán, Ellen C. Caniglia et al.|Medicine|2016Cited by 3